Clinical trial

Bilateral Subthalamic Stimulation in PD Patients With Impulse Control Disorders - STIMPulseControl

NCT06498349

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-09-05

PhaseNA

Study timeline

Study start (actual)2024-09-05Date precision: day

Registry last updated2026-01-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Impulse Control Disordersunresolved

Interventions

bilateral high frequency deep brainstimulation of the subthalamic nucleus combined with best medical treatmentPROCEDURE

best medical treatment (BMT): Adjustment of the dopaminergic medication and non-dopaminergic therapy customized for each patient according to the latest published Consensus Group RecommendationsDRUG

Sponsors & collaborators

University of Kiellead sponsor

Insel Gruppe AG, University Hospital Berncollaborator

Amsterdam University Medical Centers (UMC), Location Academic Medical Center (AMC)collaborator

Philipps University Marburgcollaborator

University Hospital Schleswig-Holsteincollaborator

Czech Technical University in Praguecollaborator

University of Pennsylvaniacollaborator

Mapped research locations

HamburgGermany1 AmsterdamNetherlands1 DresdenGermany1 CologneGermany1 ZurichSwitzerland1 BernSwitzerland1 DüsseldorfGermany1 TübingenGermany1 WürzburgGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06498349 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.